These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 25016397)

  • 1. The prevalence, incidence, prognosis, and associated conditions of resistant hypertension.
    Vega J; Bisognano JD
    Semin Nephrol; 2014 May; 34(3):247-56. PubMed ID: 25016397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.
    Calhoun DA; Jones D; Textor S; Goff DC; Murphy TP; Toto RD; White A; Cushman WC; White W; Sica D; Ferdinand K; Giles TD; Falkner B; Carey RM
    Hypertension; 2008 Jun; 51(6):1403-19. PubMed ID: 18391085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and clinical characteristics of patients with true resistant hypertension in central and Eastern Europe: data from the BP-CARE study.
    Brambilla G; Bombelli M; Seravalle G; Cifkova R; Laurent S; Narkiewicz K; Facchetti R; Redon J; Mancia G; Grassi G
    J Hypertens; 2013 Oct; 31(10):2018-24. PubMed ID: 23838657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistant hypertension: an overview of evaluation and treatment.
    Sarafidis PA; Bakris GL
    J Am Coll Cardiol; 2008 Nov; 52(22):1749-57. PubMed ID: 19022154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology, prognosis, and treatment of resistant hypertension.
    Smith SM
    Pharmacotherapy; 2013 Oct; 33(10):1071-86. PubMed ID: 23722533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.
    Calhoun DA; Jones D; Textor S; Goff DC; Murphy TP; Toto RD; White A; Cushman WC; White W; Sica D; Ferdinand K; Giles TD; Falkner B; Carey RM;
    Circulation; 2008 Jun; 117(25):e510-26. PubMed ID: 18574054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistant hypertension: a practical clinical approach.
    Muxfeldt ES; de Souza F; Salles GF
    J Hum Hypertens; 2013 Nov; 27(11):657-62. PubMed ID: 23636008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on diagnosis and treatment of resistant hypertension.
    Pimenta E
    Iran J Kidney Dis; 2011 Jul; 5(4):215-27. PubMed ID: 21725176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistant hypertension: an overview.
    McAlister FA; Lewanczuk RZ; Teo KK
    Can J Cardiol; 1996 Sep; 12(9):822-8. PubMed ID: 8842136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative epidemiology of resistant hypertension in chronic kidney disease and the general hypertensive population.
    Sarafidis PA; Georgianos PI; Zebekakis PE
    Semin Nephrol; 2014; 34(5):483-91. PubMed ID: 25416656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What is the prevalence of resistant hypertension in the United States?
    Roberie DR; Elliott WJ
    Curr Opin Cardiol; 2012 Jul; 27(4):386-91. PubMed ID: 22596184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistant systemic hypertension.
    Al-Baba B
    J Cardiovasc Med (Hagerstown); 2011 May; 12(5):340-2. PubMed ID: 21451335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and clinical characteristics of isolated-office and true resistant hypertension determined by ambulatory blood pressure monitoring.
    Ríos MT; Domínguez-Sardiña M; Ayala DE; Gomara S; Sineiro E; Pousa L; Callejas PA; Fontao MJ; Fernández JR; Hermida RC;
    Chronobiol Int; 2013 Mar; 30(1-2):207-20. PubMed ID: 23077975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Resistant hypertension and chronic kidney disease: epidemiology and prognosis].
    Seidowsky A; Massy ZA; Metzger M; Stengel B
    Nephrol Ther; 2014 Jun; 10(3):137-44. PubMed ID: 24726612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Underestimated frequency of resistant hypertension in predialysis nondiabetic patients].
    Prkacin I; Balenović D; Prkacin P; Jurina A; Santek L; Kasumović D; Cavrić G; Bulum T
    Acta Med Croatica; 2012 Jul; 66(3):229-33. PubMed ID: 23441538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].
    Amado P; Vasconcelos N; Santos I; Almeida L; Nazaré J; Carmona J
    Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The double challenge of resistant hypertension and chronic kidney disease.
    Rossignol P; Massy ZA; Azizi M; Bakris G; Ritz E; Covic A; Goldsmith D; Heine GH; Jager KJ; Kanbay M; Mallamaci F; Ortiz A; Vanholder R; Wiecek A; Zoccali C; London GM; Stengel B; Fouque D; ; ;
    Lancet; 2015 Oct; 386(10003):1588-98. PubMed ID: 26530623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation and pharmacologic approach to patients with resistant hypertension.
    Adams M; Bellone JM; Wright BM; Rutecki GW
    Postgrad Med; 2012 Jan; 124(1):74-82. PubMed ID: 22314117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and characteristics of pseudohypertension in patients with "resistant hypertension".
    Kleman M; Dhanyamraju S; DiFilippo W
    J Am Soc Hypertens; 2013; 7(6):467-70. PubMed ID: 23849622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistant hypertension, secondary hypertension, and hypertensive crises: diagnostic evaluation and treatment.
    Acelajado MC; Calhoun DA
    Cardiol Clin; 2010 Nov; 28(4):639-54. PubMed ID: 20937447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.